Free Trial
NASDAQ:IRIX

IRIDEX (IRIX) Stock Price, News & Analysis

IRIDEX logo
$1.80 +0.08 (+4.65%)
(As of 11/22/2024 ET)

About IRIDEX Stock (NASDAQ:IRIX)

Key Stats

Today's Range
$1.72
$1.87
50-Day Range
$1.36
$2.00
52-Week Range
$1.27
$3.65
Volume
26,872 shs
Average Volume
44,414 shs
Market Capitalization
$29.95 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.00
Consensus Rating
Hold

Company Overview

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. It offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform MicroPulse transscleral laser therapy; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products for use in vitrectomy procedures. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics. It markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California.

IRIDEX Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
14th Percentile Overall Score

IRIX MarketRank™: 

IRIDEX scored higher than 14% of companies evaluated by MarketBeat, and ranked 595th out of 648 stocks in the computer and technology sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    IRIDEX has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    IRIDEX has received no research coverage in the past 90 days.

  • Read more about IRIDEX's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of IRIDEX is -2.69, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of IRIDEX is -2.69, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    IRIDEX has a P/B Ratio of 11.25. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about IRIDEX's valuation and earnings.
  • Percentage of Shares Shorted

    2.49% of the float of IRIDEX has been sold short.
  • Short Interest Ratio / Days to Cover

    IRIDEX has a short interest ratio ("days to cover") of 12.4, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in IRIDEX has recently decreased by 8.02%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    IRIDEX does not currently pay a dividend.

  • Dividend Growth

    IRIDEX does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    2.49% of the float of IRIDEX has been sold short.
  • Short Interest Ratio / Days to Cover

    IRIDEX has a short interest ratio ("days to cover") of 12.4, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in IRIDEX has recently decreased by 8.02%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    IRIDEX has a news sentiment score of 0.18. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.62 average news sentiment score of Computer and Technology companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for IRIDEX this week, compared to 0 articles on an average week.
  • MarketBeat Follows

    Only 1 people have added IRIDEX to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, IRIDEX insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 7.30% of the stock of IRIDEX is held by insiders.

  • Percentage Held by Institutions

    Only 20.10% of the stock of IRIDEX is held by institutions.

  • Read more about IRIDEX's insider trading history.
Receive IRIX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IRIDEX and its competitors with MarketBeat's FREE daily newsletter.

IRIX Stock News Headlines

IRIDEX (NASDAQ:IRIX) Now Covered by Analysts at StockNews.com
“This Changes Everything” - Trump Hands Millions Massive IRS Gift
Now it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as we wait for Trump's agenda to kick in…
Iridex Corporation’s Q3 2024 Financial Performance Overview
Iridex Leadership Changes and Strategic Appointments
See More Headlines

IRIX Stock Analysis - Frequently Asked Questions

IRIDEX's stock was trading at $2.81 at the start of the year. Since then, IRIX shares have decreased by 35.9% and is now trading at $1.80.
View the best growth stocks for 2024 here
.

IRIDEX Co. (NASDAQ:IRIX) issued its quarterly earnings data on Tuesday, November, 12th. The medical equipment provider reported ($0.12) EPS for the quarter. The medical equipment provider earned $11.58 million during the quarter. IRIDEX had a negative trailing twelve-month return on equity of 192.95% and a negative net margin of 22.79%.

Shares of IRIX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that IRIDEX investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Broadcom (AVGO), Meta Platforms (META), CymaBay Therapeutics (CBAY), Arista Networks (ANET) and CrowdStrike (CRWD).

Company Calendar

Last Earnings
11/12/2024
Today
11/23/2024
Fiscal Year End
12/31/2024
Next Earnings (Estimated)
3/25/2025

Industry, Sector and Symbol

Industry
Electromedical equipment
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:IRIX
Employees
120
Year Founded
1989

Price Target and Rating

Average Stock Price Target
$2.00
High Stock Price Target
$2.00
Low Stock Price Target
$2.00
Potential Upside/Downside
+11.1%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
1 Analysts

Profitability

Net Income
$-9,570,000.00
Pretax Margin
-22.51%

Debt

Sales & Book Value

Annual Sales
$51.87 million
Book Value
$0.16 per share

Miscellaneous

Free Float
15,422,000
Market Cap
$29.95 million
Optionable
Optionable
Beta
0.80

Social Links

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

This page (NASDAQ:IRIX) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners